Long-term first-in-man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high-risk prostate cancer after radical prostatectomy

Cancer Vaccines for Genitourinary Tumors: Recent Progresses and Future Possibilities

Moving on From Sipuleucel-T: New Dendritic Cell Vaccine Strategies for Prostate Cancer

High Health-Related Quality of Life During Dendritic Cell Vaccination Therapy in Patients With Castration-Resistant Prostate Cancer

Targeting STAT3 enhances NDV-induced immunogenic cell death in prostate cancer cells

Substantial tumor regression in prostate cancer patient with extensive skeletal metastases upon Immunotherapy (APCEDEN): A case report

Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer

Substantial remission of prostate adenocarcinoma with dendritic cell therapy APCEDEN in combination with chemotherapy

Past, Current, and Future of Immunotherapies for Prostate Cancer

Capacitive hyperthermia as an alternative to brachytherapy in DNA damages of human prostate cancer cell line (DU-145)